ACADIA Pharmaceuticals Inc (ACAD): Pangali Forward P/E
ACADIA Pharmaceuticals combines a niche-capture strategy with the management of patent disputes regarding Nuplazid. The company's forward P/E reflects valuation dynamics, with the current metric standing at 17.50. Its monopoly pricing power over orphan drugs provides the business with stability until the expiration of its exclusive rights.
Rincian analitis perusahaan ACADIA Pharmaceuticals
- kuotasi lan prakiraan analis:
- data kapitalisasi bursa:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal ACADIA Pharmaceuticals|ACAD - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas ACADIA Pharmaceuticals|ACAD - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku ACADIA Pharma|ACAD - Kewajiban jangka dawa|Utang jangka cendhak perusahaan ACADIA Pharmaceuticals|Rasio cepet acadia-pharm.com
- statistik bathi lan rasio pasar:
ACAD - Bathi resik|Bathi sing dikarepake ACADIA Pharmaceuticals|ACAD - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep ACADIA Pharmaceuticals Inc|ACAD - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA ACADIA Pharma|ACAD - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) ACADIA Pharmaceuticals|ACAD - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan acadia-pharm.com|ACAD - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep ACADIA Pharmaceuticals
Pambiji fundamental:ACAD ACADIA Pharmaceuticals Inc.
Forward P/E is calculated as the ratio of a stock's current market value to its projected earnings per share, measuring the market's willingness to pay a premium for future cash flows. For ACADIA Pharmaceuticals (ACAD), the trajectory of the company's future price-to-earnings multiple reflects expectations for the scalability of its CNS biotech solutions, where low production costs combined with global patent coverage should drive rapid net income growth.
Analisis pesaing ACADIA Pharmaceuticals
Pangali Forward P/E BIIB|Prakiraan rega marang bathi Neurocrine NBIX|Pangali Forward P/E RGC (Regencell)|Pangali Forward P/E Axsome Corp AXSM|Xenon Pharmaceuticals - Pangali Forward P/E|VKTX (vikingtherapeutics.com) - Rasio rega marang bathi mangsa ngarep|SUPN: Pangali Forward P/E|CPRX - Kapitalisasi marang proyeksi bathi|DNLI (Denali Therapeutics Inc) - Pangali Forward P/E|Pangali Forward P/E Harmony Corp|Prakiraan rega marang bathi BHVN (Biohaven Ltd.)|AMLX (amylyx.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Trevi Therapeutics, Inc. TRVI|PRAX (Praxis Precision Medicines Inc) - Rasio rega marang bathi sing dikarepake|Anavex Corp - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi CBLL (CeriBell EEG)|PRTA: Pangali Forward P/E|Alector (ALEC) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Annexon|OMER: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Neurogene Corp (NGNE)|Prakiraan rega marang bathi AC Immune Inc ACIU|Pangali Forward P/E VYGR (Voyager Therapeutics)|Pangali Forward P/E neumoratx.com NMRA|Scilex - Pangali Forward P/E|Tevogen Bio Holdings Inc. (TVGN) - Prakiraan rega marang bathi|ACOG: Pangali Forward P/E|Rasio prakiraan rega marang bathi Cognition Therapeutics Inc. (CGTX)|Prakiraan rega marang bathi IKT|Pangali Forward P/E cassavasciences.com|Prakiraan rega marang bathi ASRT (Assertio Holdings, Inc.)|Rasio kapitalisasi marang bathi mangsa ngarep COYA|Pangali Forward P/E VTGN (Vistagen)|Kapitalisasi marang proyeksi bathi Ovid Therapeutics Inc (OVID)|Acumen Pharmaceuticals - Pangali Forward P/E|cervomed.com (CRVO) - Prakiraan rega marang bathi|ATHE: Pangali Forward P/E|Clene (CLNN) - Pangali Forward P/E|Rega marang bathi mangsa ngarep PepGen Inc|Rega marang bathi mangsa ngarep JUNS|Rega marang bathi mangsa ngarep Relmada Therapeutics (RLMD)|Kapitalisasi marang proyeksi bathi annovisbio.com|Pangali Forward P/E GRCE (Grace Therapeutics)|Pangali Forward P/E Firefly Neuroscience, Inc. AIFF|ANEW Medical, Inc. - Pangali Forward P/E|NeuroSense Therapeutics (NRSN) - Prakiraan rega marang bathi|RVPH: Pangali Forward P/E|MetaVia (MTVA) - Pangali Forward P/E|NRXS (NeurAxis) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep HSDT (Helius Medical Technologies Inc.)|Rega marang bathi mangsa ngarep Passage Bio, Inc. (PASG)|bionomics.com.au - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E NERV (Minerva Neurosciences)|athira.com (ATHA) - Rasio prakiraan rega marang bathi|ADXN: Prakiraan rega marang bathi|ALZN - Pangali Forward P/E|cyclerion.com (CYCN) - Rega marang bathi mangsa ngarep|Protagenic Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Pasithea Therapeutics Corp|Rasio prakiraan rega marang bathi Cortigent Medical CRGT|Pangali Forward P/E ATXI|Pangali Forward P/E Brainstorm Cell Therapeutics Inc. (BCLI)|Pangali Forward P/E CARA (Cara Therapeutics, Inc)|CHRO - Prakiraan rega marang bathi|Eliem - Pangali Forward P/E|ITCI - Pangali Forward P/E|LBPH: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep MRNS|NKGN (NKGen) - Pangali Forward P/E|NeuroBo Pharma (NRBO) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SAGE|Pangali Forward P/E synaptogen.com (SNPX)|Trevena - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi VIGL|WENA - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake CERE
